Literature DB >> 21792600

[Pregnancy under immunosuppression].

J Walldorf1, M M Dollinger, T Seufferlein.   

Abstract

The desire to have children and pregnancy itself are important topics in the treatment of patients under immunosuppression. In this review the risks of frequently prescribed immunosuppressants are discussed regarding the safety of mother and child during and after pregnancy. Knowledge of the specific risks of immunosuppressants in pregnancy is important to balance the therapy between the patients' desire to be treated most effectively and to deliver a healthy child after an uncomplicated pregnancy. Generally, an interdisciplinary approach is advisable in treating and counseling immunosuppressed patients with a desire to have children and during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21792600     DOI: 10.1007/s00108-011-2822-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  32 in total

1.  Developmental well-being in offspring of women receiving cyclosporine post-renal transplant.

Authors:  C W Stanley; R Gottlieb; R Zager; J Eisenberg; R Richmond; M J Moritz; V T Armenti
Journal:  Transplant Proc       Date:  1999 Feb-Mar       Impact factor: 1.066

2.  Successful pregnancies after human renal transplantation.

Authors:  J E MURRAY; D E REID; J H HARRISON; J P MERRILL
Journal:  N Engl J Med       Date:  1963-08-15       Impact factor: 91.245

3.  Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients.

Authors:  Vimala Christopher; Thawab Al-Chalabi; Paul D Richardson; Paolo Muiesan; Mohammed Rela; Nigel D Heaton; John G O'Grady; Michael A Heneghan
Journal:  Liver Transpl       Date:  2006-07       Impact factor: 5.799

4.  Paternal exposure to methotrexate and pregnancy outcomes.

Authors:  Delphine Beghin; Marie-Pierre Cournot; Catherine Vauzelle; Elisabeth Elefant
Journal:  J Rheumatol       Date:  2011-01-15       Impact factor: 4.666

5.  Placental transfer of methylprednisolone following maternal intravenous administration.

Authors:  G G Anderson; Y Rotchell; D G Kaiser
Journal:  Am J Obstet Gynecol       Date:  1981-07-15       Impact factor: 8.661

6.  Infliximab and semen quality in men with inflammatory bowel disease.

Authors:  Uma Mahadevan; Jonathan P Terdiman; Jeffrey Aron; Steve Jacobsohn; Paul Turek
Journal:  Inflamm Bowel Dis       Date:  2005-04       Impact factor: 5.325

7.  Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Authors:  Jessica Coelho; Laurent Beaugerie; Jean Frédéric Colombel; Xavier Hébuterne; Eric Lerebours; Marc Lémann; Philippe Baumer; Jacques Cosnes; Arnaud Bourreille; Jean Pierre Gendre; Philippe Seksik; Antoine Blain; Etienne H Metman; Andrée Nisard; Guillaume Cadiot; Michel Veyrac; Benoît Coffin; Xavier Dray; Fabrice Carrat; Philippe Marteau
Journal:  Gut       Date:  2010-11-29       Impact factor: 23.059

Review 8.  Pregnancy and liver transplantation.

Authors:  Bijal Surti; Jennifer Tan; Sammy Saab
Journal:  Liver Int       Date:  2008-11       Impact factor: 5.828

9.  Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.

Authors:  Vincent T Armenti; John A Daller; Serban Constantinescu; Patricio Silva; John S Radomski; Michael J Moritz; William J Gaughan; Carolyn H McGrory; Lisa A Coscia
Journal:  Clin Transpl       Date:  2006

Review 10.  Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.

Authors:  Christina D Chambers; Zuhre N Tutuncu; Diana Johnson; Kenneth L Jones
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.